Operating Lease, Right-of-Use Asset of IRONWOOD PHARMACEUTICALS INC from 01 Jan 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
IRONWOOD PHARMACEUTICALS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2025.
  • IRONWOOD PHARMACEUTICALS INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $9,340,000, a 15% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

IRONWOOD PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $9,340,000 -$1,688,000 -15% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $9,775,000 -$1,655,000 -14% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $10,201,000 -$1,622,000 -14% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $10,619,000 -$1,589,000 -13% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $11,028,000 -$1,558,000 -12% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $11,430,000 -$1,526,000 -12% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $11,823,000 -$1,496,000 -11% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $12,208,000 -$1,466,000 -11% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $12,586,000 -$1,437,000 -10% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $12,956,000 -$1,409,000 -9.8% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $13,319,000 -$1,381,000 -9.4% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $13,674,000 -$1,354,000 -9% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $14,023,000 -$1,327,000 -8.6% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q3 2022 $14,365,000 -$1,301,000 -8.3% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $14,700,000 -$1,275,000 -8% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q1
Q1 2022 $15,028,000 -$1,251,000 -7.7% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $15,350,000 -$1,226,000 -7.4% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $15,666,000 -$1,202,000 -7.1% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $15,975,000 -$1,181,000 -6.9% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $16,279,000 -$1,168,000 -6.7% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $16,576,000 -$1,167,000 -6.6% 31 Dec 2020 10-K 18 Feb 2022 2021 FY
Q3 2020 $16,868,000 -$2,925,000 -15% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $17,156,000 -$8,413,000 -33% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $17,447,000 -$67,386,000 -79% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $17,743,000 -$70,557,000 -80% 31 Dec 2019 10-K 17 Feb 2021 2020 FY
Q3 2019 $19,793,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $25,569,000 30 Jun 2019 10-Q 30 Jul 2019 2019 Q2
Q1 2019 $84,833,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $88,300,000 01 Jan 2019 10-K 13 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.